Hyperuricemia is associated with acute kidney injury and all-cause mortality in hospitalized patients

被引:25
作者
Kang, Min Woo [1 ]
Chin, Ho Jun [1 ,2 ]
Joo, Kwon-Wook [1 ]
Na, Ki Young [1 ,2 ]
Kim, Sejoong [1 ,2 ]
Han, Seung Seok [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Internal Med, 103 Daehakro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, 82 Gumi Ro 173Beon Gil, Seongnam Si 13620, Gyeonggi Do, South Korea
基金
新加坡国家研究基金会;
关键词
acute kidney injury; hyperuricemia; mortality; survival; uric acid; SERUM URIC-ACID; RISK-FACTOR; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RENAL-DISEASE; PROGRESSION; PREVENTION; FEATURES; HEALTH; LEVEL;
D O I
10.1111/nep.13559
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim Hyperuricemia is a risk factor for high morbidity and mortality in several diseases. However, the relationship between uric acid (UA) and the risk of acute kidney injury (AKI) and mortality remain unresolved in hospitalized patients. Methods Data from 18 444 hospitalized patients were retrospectively reviewed. The odds ratio (OR) for AKI and the hazard ratio (HR) for all-cause mortality were calculated based on the UA quartiles after adjustment for multiple variables. All analyses were performed after stratification by sex. Results The fourth quartile group (male, UA > 6.7 mg/dL; female, UA > 5.4 mg/dL) showed a higher risk of AKI compared with the first quartile group (male, UA < 4.5 mg/dL; female, UA < 3.6 mg/dL), with the following OR: 3.2 (2.55-4.10) in males (P < 0.001); and 3.1 (2.40-4.19) in females (P < 0.001). There were more patients who did not recover from AKI in the fourth quartile compared with the first quartile, with the following OR: 2.0 (1.32-3.04) in males (P = 0.001) and 2.4 (1.43-3.96) in females (P = 0.001). The fourth quartile group had a higher risk of all-cause mortality compared with the first quartile group, with the following HR: 1.4 (1.20-1.58) in males (P < 0.001) and 1.2 (1.03-1.46) in females (P = 0.019). The in-hospital mortality risk was also higher in the fourth quartile compared with the first quartile, which was significant only in males (OR, 2.1 (1.33-3.31) (P = 0.002)). Conclusion Hyperuricemia increases the risks of AKI and all-cause mortality in hospitalized patients.
引用
收藏
页码:718 / 724
页数:7
相关论文
共 45 条
[1]  
ANTON FM, 1986, METABOLISM, V35, P343
[2]   Cellular pathophysiology of ischemic acute kidney injury [J].
Bonventre, Joseph V. ;
Yang, Li .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) :4210-4221
[3]   Epidemiology of Acute Kidney Injury in the Intensive Care Unit [J].
Case, James ;
Khan, Supriya ;
Khalid, Raeesa ;
Khan, Akram .
CRITICAL CARE RESEARCH AND PRACTICE, 2013, 2013
[4]   Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study [J].
Chen, Jiunn-Horng ;
Lan, Joung-Liang ;
Cheng, Chi-Fung ;
Liang, Wen-Miin ;
Lin, Hsiao-Yi ;
Tsay, Gregory J. ;
Yeh, Wen-Ting ;
Pan, Wen-Harn .
PLOS ONE, 2015, 10 (12)
[5]   Acute kidney injury, mortality, length of stay, and costs in hospitalized patients [J].
Chertow, GM ;
Burdick, E ;
Honour, M ;
Bonventre, JV ;
Bates, DW .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11) :3365-3370
[6]   Admission hyperuricemia increases the risk of acute kidney injury in hospitalized patients [J].
Cheungpasitporn, Wisit ;
Thongprayoon, Charat ;
Harrison, Andrew M. ;
Erickson, Stephen B. .
CLINICAL KIDNEY JOURNAL, 2016, 9 (01) :51-56
[7]   Hyperuricemia Is an Independent Risk Factor for Mortality Only if Chronic Kidney Disease Is Present [J].
Chung, Wookyung ;
Kim, Ae Jin ;
Ro, Han ;
Chang, Jae Hyun ;
Lee, Hyun Hee ;
Jung, Ji Yong .
AMERICAN JOURNAL OF NEPHROLOGY, 2013, 37 (05) :452-461
[8]  
Davies A., 2017, BMJ Open Qual, V6, DOI [10.1136/bmjoq-2017-000006, DOI 10.1136/BMJOQ-2017-000006]
[9]  
Desideri G, 2014, EUR REV MED PHARMACO, V18, P1295
[10]   Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study [J].
Desideri G. ;
Virdis A. ;
Casiglia E. ;
Borghi C. ;
Cicero A.F.G. ;
Muiesan M.L. ;
Rosei E.A. ;
Salvetti M. ;
Ungar A. ;
Rivasi G. ;
Pontremoli R. ;
Viazzi F. ;
Grassi G. ;
Bombelli M. ;
Facchetti R. ;
Ferri C. ;
Bernardino B. ;
Galletti F. ;
D’Elia L. ;
Palatini P. ;
Tikhonoff V. ;
Barbagallo C.M. ;
Verdecchia P. ;
Masi S. ;
Mallamaci F. ;
Cirillo M. ;
Rattazzi M. ;
Pauletto P. ;
Cirillo P. ;
Gesualdo L. ;
Mazza A. ;
Giannattasio C. ;
Maloberti A. ;
Volpe M. ;
Tocci G. ;
Iaccarino G. ;
Nazzaro P. .
High Blood Pressure & Cardiovascular Prevention, 2018, 25 (2) :197-202